---
title: "Goldman Sachs Sticks to Its Buy Rating for Immatics (IMTX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296312841.md"
description: "Goldman Sachs analyst Rajan Sharma maintained a Buy rating on Immatics (IMTX) with an $11.80 price target, despite shares closing at $9.09. Sharma holds a 3-star rating with a 50.43% success rate. In contrast, the broader market consensus for Immatics is a Strong Buy with an average price target of $14.40."
datetime: "2026-08-19T06:35:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296312841.md)
  - [en](https://longbridge.com/en/news/296312841.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296312841.md)
generator: "portal-rs"
---

# Goldman Sachs Sticks to Its Buy Rating for Immatics (IMTX)

In a report released yesterday, Rajan Sharma from Goldman Sachs maintained a Buy rating on Immatics, with a price target of $11.80. The company’s shares closed yesterday at $9.09.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Sharma is a 3-star analyst with an average return of 2.5% and a 50.43% success rate. Sharma covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Autolus Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Immatics with a $14.40 average price target.

### Related Stocks

- [IMTX.US](https://longbridge.com/en/quote/IMTX.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [AUTL.US](https://longbridge.com/en/quote/AUTL.US.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)
- [IMTXW.US](https://longbridge.com/en/quote/IMTXW.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [GSK.UK](https://longbridge.com/en/quote/GSK.UK.md)
- [GSK.WI.US](https://longbridge.com/en/quote/GSK.WI.US.md)

## Related News & Research

- [This Entegris Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday](https://longbridge.com/en/news/301844395.md)
- [HybridDIA Update Could Shape The Case For Immatics Stock](https://longbridge.com/en/news/300862720.md)
- [Perceptive Life Sciences Master Fund acquires USD 7.5 million in Immatics shares](https://longbridge.com/en/news/297226483.md)
- [Bank of America Q3 Preview: Stock Down in 2026, Could 5th Straight Double Beat Change Momentum?](https://longbridge.com/en/news/301739892.md)
- [Intuit vs. Oracle: One Software Stock Faces Competition, the Other Is a Risk Worth Taking, Says Top Investor](https://longbridge.com/en/news/301861616.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**